Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daniel S Peeper

25PUBLICATIONS
126CO-AUTHORS
Molecular targetsHaematological tumoursTumour immunologyCellular immunologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

Sort by Publication Date:
|Mar 11, 2026
Targeting the Non-Homologous End Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin by Enhancing p53-Mediated Senescence.

Thijs Jalving, Carine Dufau, Juan Simon Nieto

|Nov 28, 2025
Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing.

Anastasia Piskopou, David W Vredevoogd, Xiangjun Kong

|Nov 28, 2025
Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?

Daphne van der Geest, Alex van Vliet, Daniel S Peeper

|Nov 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samples.

Sofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto

|Jul 04, 2025
Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers.

Tim Arnoldus, Alex van Vliet, Onno B Bleijerveld

|Jan 21, 2025
TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors.

Jennifer Wagner, David Vredevoogd, Xin Yu

Pageof 5

Frequent Collaborators

7 joint publications

Christian U Blank

6 joint publications

David W Vredevoogd

5 joint publications

Onno B Bleijerveld

4 joint publications

John B A G Haanen

4 joint publications

Julia Boshuizen

3 joint publications

Reuven Agami

3 joint publications

Petros Dimitriadis

3 joint publications

Julien Champagne

3 joint publications

Chun-Pu Lin

3 joint publications

Thomas Kuilman

Frequent Collaborators

7 joint publications

Christian U Blank

6 joint publications

David W Vredevoogd

5 joint publications

Onno B Bleijerveld

4 joint publications

John B A G Haanen

Top Related Videos

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on : Apr 28, 2021

4.7K
Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
09:15

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells

Published on : Oct 20, 2022

2.7K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

9.2K
See more related videos

Top Related Videos

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on : Apr 28, 2021

4.7K
Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
09:15

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells

Published on : Oct 20, 2022

2.7K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

9.2K
See more related videos